Fisher G J, Esmann J, Griffiths C E, Talwar H S, Duell E A, Hammerberg C, Elder J T, Finkel L J, Karabin G D, Nickoloff B J
Department of Dermatology, University of Michigan Medical School, Ann Arbor.
J Invest Dermatol. 1991 May;96(5):699-707. doi: 10.1111/1523-1747.ep12470632.
Histologic and clinical improvement of sun-exposed skin following topical treatment with retinoic acid has been reported. Daily application of retinoic acid typically results within 2-5 d in an erythematous scaling reaction, which lessens with continued usage. The cellular, immunologic, and biochemical basis of this retinoid reaction and its role in the repair of photodamaged skin are not known. To investigate the retinoid reaction in man, we have treated non-sun-exposed skin with 0.1% retinoic acid cream (Retin-A, Ortho Pharmaceutical Corporation, Raritan, NJ) under occlusion for 4 d to induce erythema and then examined changes in 1) histology, 2) expression of cell-surface molecules, 3) the enzymes and second messengers of the phospholipase C/protein kinase C signal-transduction system, 4) levels of eicosanoids, and 5) levels of interleukin-1 protein and mRNA. These parameters were chosen for measurement both because they are indicators of epidermal function and previous studies suggest they may be responsive to retinoic acid treatment. Epidermal cell growth as judged by increased epidermal thickness and mitotic figures was significantly increased in retinoic acid-treated skin compared to vehicle-treated controls. Increased numbers of CD4+ T cells accompanied by prominence of dermal dendrocytes in the papillary dermis and focal keratinocyte expression of intercellular adhesion molecule-1 were observed in retinoic acid-treated biopsies. Phosphoinositide-specific phospholipase C activity and 1,2-diacylglycerol content were also elevated in retinoic acid-treated epidermis. Protein kinase C activity was reduced by one third in both the soluble and membrane fraction, suggesting down-regulation. Surprisingly, in view of the inflammatory nature of the retinoid reaction, no increases were observed in arachidonic acid, its metabolites, interleukin-1 alpha, or interleukin-1 beta. To examine the specificity of the retinoid reaction, subjects were treated with the irritant sodium lauryl sulfate, under conditions that resulted in a reaction clinically similar to that observed with retinoic acid. The histologic alterations induced by sodium lauryl sulfate were found to be indistinguishable from those induced by retinoic acid. These data indicate that, although a wide range of cellular and molecular alterations occur in retinoic acid-treated skin, these changes may not be necessarily specific or unique for retinoic acid.
已有报道称,外用维甲酸治疗后,暴露于阳光下皮肤的组织学和临床症状有所改善。每日涂抹维甲酸通常会在2 - 5天内引发红斑鳞屑反应,持续使用后该反应会减轻。这种类维生素A反应的细胞、免疫和生化基础及其在光损伤皮肤修复中的作用尚不清楚。为了研究人体中的类维生素A反应,我们用0.1%维甲酸乳膏(维甲酸,奥索制药公司,拉里坦,新泽西州)封闭处理非暴露于阳光下的皮肤4天以诱导红斑,然后检查以下方面的变化:1)组织学;2)细胞表面分子的表达;3)磷脂酶C/蛋白激酶C信号转导系统的酶和第二信使;4)类花生酸水平;5)白细胞介素-1蛋白和mRNA水平。选择这些参数进行测量,既是因为它们是表皮功能的指标,也是因为先前的研究表明它们可能对维甲酸治疗有反应。与用赋形剂处理的对照组相比,维甲酸处理的皮肤中,通过增加的表皮厚度和有丝分裂象判断的表皮细胞生长显著增加。在维甲酸处理的活检组织中,观察到CD4 + T细胞数量增加,同时乳头真皮中的真皮树突状细胞突出,角质形成细胞间粘附分子-1呈局灶性表达。维甲酸处理的表皮中,磷酸肌醇特异性磷脂酶C活性和1,2 - 二酰甘油含量也升高。可溶性和膜部分的蛋白激酶C活性均降低了三分之一,表明存在下调。令人惊讶的是,鉴于类维生素A反应的炎症性质,未观察到花生四烯酸及其代谢产物、白细胞介素-1α或白细胞介素-1β增加。为了检验类维生素A反应的特异性,让受试者在导致临床上与维甲酸观察到的反应相似的条件下,用刺激性的十二烷基硫酸钠进行处理。发现十二烷基硫酸钠诱导的组织学改变与维甲酸诱导的改变无法区分。这些数据表明,尽管维甲酸处理的皮肤中发生了广泛的细胞和分子改变,但这些变化不一定对维甲酸具有特异性或独特性。